ProfileGDS4718 / 218982_s_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 85% 78% 84% 81% 76% 93% 93% 83% 76% 82% 84% 75% 94% 94% 92% 85% 82% 90% 92% 82% 82% 81% 82% 83% 82% 91% 79% 89% 80% 91% 89% 89% 74% 82% 90% 91% 93% 82% 80% 83% 83% 87% 86% 93% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]8.4948185
GSM549102patient 115, normal, homogenized [OPG study]7.579478
GSM549104patient 119, normal, homogenized [OPG study]8.3522484
GSM549108patient 138, normal, homogenized [OPG study]7.8072581
GSM549119patient 077, normal, homogenized [OPG study]7.3388176
GSM549133patient 032, cancer, homogenized [OPG study]9.8704693
GSM549139patient 042, cancer, homogenized [OPG study]9.7796293
GSM549099patient 107, normal, homogenized [OPG study]8.0809583
GSM549109patient 139, normal, homogenized [OPG study]7.3822276
GSM549110patient 046, normal, homogenized [OPG study]8.0286482
GSM549114patient 063, normal, homogenized [OPG study]8.4800984
GSM549122patient 082, normal, homogenized [OPG study]7.3464775
GSM549134patient 033, cancer, homogenized [OPG study]9.950194
GSM549136patient 036, cancer, homogenized [OPG study]9.9234794
GSM549140patient 044, cancer, homogenized [OPG study]9.6489992
GSM549111patient 047, normal, homogenized [OPG study]8.5379885
GSM549113patient 057, normal, homogenized [OPG study]8.1500182
GSM549132patient 031, cancer, homogenized [OPG study]9.2076590
GSM549137patient 038, cancer, homogenized [OPG study]9.5247492
GSM549142patient 047, cancer, homogenized [OPG study]7.8332282
GSM549100patient 110, normal, homogenized [OPG study]8.0652182
GSM549107patient 135, normal, homogenized [OPG study]7.9350381
GSM549115patient 068, normal, homogenized [OPG study]8.1616982
GSM549116patient 072, normal, homogenized [OPG study]8.2430983
GSM549120patient 078, normal, homogenized [OPG study]8.1456582
GSM549131patient 030, cancer, homogenized [OPG study]9.4573991
GSM549118patient 074, normal, homogenized [OPG study]7.7577479
GSM549129patient 027, cancer, homogenized [OPG study]8.9297289
GSM549123patient 088, normal, homogenized [OPG study]7.8256580
GSM549124patient 006, cancer, homogenized [OPG study]9.2580191
GSM549126patient 015, cancer, homogenized [OPG study]8.9400389
GSM549128patient 025, cancer, homogenized [OPG study]9.0067589
GSM549103patient 117, normal, homogenized [OPG study]7.1109274
GSM549117patient 073, normal, homogenized [OPG study]8.1131382
GSM549138patient 041, cancer, homogenized [OPG study]9.1505490
GSM549141patient 045, cancer, homogenized [OPG study]9.3845491
GSM549130patient 028, cancer, homogenized [OPG study]9.6700893
GSM549101patient 111, normal, homogenized [OPG study]8.0764982
GSM549105patient 128, normal, homogenized [OPG study]7.8558480
GSM549106patient 134, normal, homogenized [OPG study]8.3283983
GSM549112patient 048, normal, homogenized [OPG study]8.2760583
GSM549125patient 011, cancer, homogenized [OPG study]8.6797787
GSM549127patient 024, cancer, homogenized [OPG study]8.5959386
GSM549135patient 035, cancer, homogenized [OPG study]9.855693